Terms: = Colorectal cancer AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287 AND Prognosis
6 results:
1. Chemokine‑ and chemokine receptor-based subtypes predict prognosis, immunotherapy and chemotherapy response in colorectal cancer patients.
Zhu W; Zhao S; Cheng X; Wu C; Liu Z; Huang J
Int Immunopharmacol; 2024 Jun; 134():112172. PubMed ID: 38703566
[TBL] [Abstract] [Full Text] [Related]
2. Identification of BGN and THBS2 as metastasis-specific biomarkers and poor survival key regulators in human colon cancer by integrated analysis.
He Z; Lin J; Chen C; Chen Y; Yang S; Cai X; He Y; Liu S
Clin Transl Med; 2022 Nov; 12(11):e973. PubMed ID: 36377223
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical expression of Fascin-1 in colorectal cancer in relation to clinical and pathological parameters.
Piskor BM; Pryczynicz A; Lubowicka E; Miniewska K; Zinczuk J; Zareba K; Guzinska-Ustymowicz K
Folia Histochem Cytobiol; 2018; 1(2):106-112. PubMed ID: 29888780
[TBL] [Abstract] [Full Text] [Related]
4. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer.
Torres S; Bartolomé RA; Mendes M; Barderas R; Fernandez-Aceñero MJ; Peláez-García A; Peña C; Lopez-Lucendo M; Villar-Vázquez R; de Herreros AG; Bonilla F; Casal JI
Clin Cancer Res; 2013 Nov; 19(21):6006-19. PubMed ID: 24025712
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
Huang L; Xu Y; Cai G; Guan Z; Cai S
Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787
[TBL] [Abstract] [Full Text] [Related]
6. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract] [Full Text] [Related]
